ASAN Q1 2026 Earnings EPS Beats Estimates as Shares Edge Lower COYA Q1 2026 Earnings Narrowed Loss Beats Estimates Stock Rises on Efficiency Gains APEI Q1 2026 Earnings EPS Surges Past Estimates by 38 Yet Stock Slips Innate Pharma IPHA Q1 2026 Earnings Deep EPS Miss Weighs on Shares as Pipeline Progress Remains in Focus AEVA Q1 2026 Earnings EPS Beat Driven by Cost Discipline Amid PreRevenue Stage Skillz Q1 2026 Earnings EPS Misses Estimates as Revenue Data Remains Withheld